Enables pharmaceutical companies to automate lifecycle assessments and product carbon footprints at scale, supporting PAS2050 readiness, Scope 3 transparency and data-driven decisions to accelerate the industry's transition toward sustainable, low-carbon product portfolios.
No comments available.
Leave your rating & comment